Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |